Home/Health & Medicine/Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer

Essay, 1 pages (100 words)

Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer

Subject: Health & Medicine

Info

Published: December 20, 2021
Updated: December 20, 2021
University / College: University of Tasmania
Language: English
Downloads: 34

An Erratum on
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

by La Ferla, M., Lessi, F., Aretini, P., Pellegrini, D., Franceschi, S., Tantillo, E., et al. (2019). Front. Oncol. 9: 547. doi: 10. 3389/fonc. 2019. 00547

Due to a production error, the affiliation for Antonio G. Naccarato was incorrectly given as the “ Department of Cell and Developmental Biology, the Hebrew University of Jerusalem, Jerusalem, Israel” (affiliation 8). The correct affiliation is the “ Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, Pisa, Italy” (affiliation 10).

The publisher apologizes for this mistake. The original article has been updated.

Thank's for Your Vote!

This work, titled "Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer" was written and willingly shared by a fellow student. This sample can be utilized as a research and reference resource to aid in the writing of your own work. Any use of the work that does not include an appropriate citation is banned.

If you are the owner of this work and don’t want it to be published on AssignBuster, request its removal.

Request Removal

Cite this Essay

References

AssignBuster. (2021) 'Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer'. 20 December.

Reference

AssignBuster. (2021, December 20). Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer. Retrieved from https://assignbuster.com/erratum-ankrd44-gene-silencing-a-putative-role-in-trastuzumab-resistance-in-her2-like-breast-cancer/

References

AssignBuster. 2021. "Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer." December 20, 2021. https://assignbuster.com/erratum-ankrd44-gene-silencing-a-putative-role-in-trastuzumab-resistance-in-her2-like-breast-cancer/.

1. AssignBuster. "Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer." December 20, 2021. https://assignbuster.com/erratum-ankrd44-gene-silencing-a-putative-role-in-trastuzumab-resistance-in-her2-like-breast-cancer/.

Bibliography

AssignBuster. "Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer." December 20, 2021. https://assignbuster.com/erratum-ankrd44-gene-silencing-a-putative-role-in-trastuzumab-resistance-in-her2-like-breast-cancer/.

Work Cited

"Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer." AssignBuster, 20 Dec. 2021, assignbuster.com/erratum-ankrd44-gene-silencing-a-putative-role-in-trastuzumab-resistance-in-her2-like-breast-cancer/.

Get in Touch

Please, let us know if you have any ideas on improving Erratum: ankrd44 gene silencing: a putative role in trastuzumab resistance in her2-like breast cancer, or our service. We will be happy to hear what you think: [email protected]